Related references
Note: Only part of the references are listed.HIV-1 Entry Cofactor: Functional cDNA Cloing of a Seven-Transmembrane, G protein-Coupled Receptor
Yu Feng et al.
JOURNAL OF IMMUNOLOGY (2011)
Small-Molecule CD4 Mimics Interact with a Highly Conserved Pocket on HIV-1 gp120
Navid Madani et al.
STRUCTURE (2008)
Relationship of HIV-1 and SIV envelope glycoprotein trimer occupation and neutralization
Emma T. Crooks et al.
VIROLOGY (2008)
Retroviruses can establish filopodial bridges for efficient cell-to-cell transmission
Nathan M. Sherer et al.
NATURE CELL BIOLOGY (2007)
Structural definition of a conserved neutralization epitope on HIV-1 gp120
Tongqing Zhou et al.
NATURE (2007)
Inhibition of human immunodeficiency virus envelope glycoprotein-mediated single cell lysis by low-molecular-weight antagonists of viral entry
Navid Madani et al.
JOURNAL OF VIROLOGY (2007)
Time frames for neutralization during the human immunodeficiency virus type 1 entry phase, as monitored in synchronously infected cell cultures
Hillel Haim et al.
JOURNAL OF VIROLOGY (2007)
The HIV Env variant N283 enhances macrophage tropism and is associated with brain infection and dementia
Rebecca L. Dunfee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Thermodynamics of binding of a low-molecular-weight CD4 mimetic to HIV-1 gp120
Arne Schon et al.
BIOCHEMISTRY (2006)
Kinetic dependence to HIV-1 entry inhibition
H. Kirby Steger et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4
Q Zhao et al.
VIROLOGY (2005)
Ternary complex formation of human immunodeficiency virus type 1 Env, CD4, and chemokine receptor captured as an intermediate of membrane fusion
SR Mkrtchyan et al.
JOURNAL OF VIROLOGY (2005)
Synchronized infection of cell cultures by magnetically controlled virus
H Haim et al.
JOURNAL OF VIROLOGY (2005)
Small-molecule inhibitors of HIV-1 entry block receptor-induced conformational changes in the viral envelope glycoproteins
ZH Si et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Characterization of the outer domain of the gp120 glycoprotein from human immunodeficiency virus type 1
XZ Yang et al.
JOURNAL OF VIROLOGY (2004)
Rational design of a CD4 mimic that inhibits HIV-1 entry and exposes cryptic neutralization epitopes
L Martin et al.
NATURE BIOTECHNOLOGY (2003)
HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites
PD Kwong et al.
NATURE (2002)
Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus
E Chertova et al.
JOURNAL OF VIROLOGY (2002)
Biochemical and biological characterization of a dodecameric CD4-Ig fusion protein - Implications for therapeutic and vaccine strategies
J Arthos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The stoichiometry of trimeric SIV glycoprotein interaction with CD4 differs from that of anti-envelope antibody Fab fragments
M Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Expression, purification, and characterization of recombinant HIV gp140 - The gp41 ectodomain of HIV or simian immunodeficiency virus is sufficient to maintain the retroviral envelope glycoprotein as a trimer
CWH Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
1,3,4-trisubstituted pyrrolidine CCR5 receptor antagonists. Part 2: Lead optimization affording selective, orally bioavailable compounds with potent anti-HIV activity
JJ Hale et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2001)
Ligand binding characteristics of CXCR4 incorporated into paramagnetic proteoliposomes
GJ Babcock et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
HIV-1 gp41 six-helix bundle formation occurs rapidly after the engagement of gp120 by CXCR4 in the HIV-1 Env-mediated fusion process
SA Gallo et al.
BIOCHEMISTRY (2001)
Antagonists of the human CCR5 receptor as anti-HIV-1 agents.: Part 4:: Synthesis and structure-activity relationships for 1-[N(methyl)-N-(phenylsulfonyl)amino]-2-(phenyl)-4-(4-(N-(alkyl)-N- (benzyloxycarbonyl)amino)piperidin-1-yl)butanes
PE Finke et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2001)
The highly conserved C-terminal dileucine motif in the cytosolic domain of the human immunodeficiency virus type 1 envelope glycoprotein is critical for its association with the AP-1 clathrin adapter
S Wyss et al.
JOURNAL OF VIROLOGY (2001)
Antibody 17b binding at the coreceptor site weakens the kinetics of the interaction of envelope glycoprotein gp120 with CD4
WT Zhang et al.
BIOCHEMISTRY (2001)
Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion
GB Melikyan et al.
JOURNAL OF CELL BIOLOGY (2000)
Energetics of the HIV gp120-CD4 binding reaction
DG Myszka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Toward a more accurate quantitation of the activity of recombinant retroviruses: Alternatives to titer and multiplicity of infection (vol 74, pg 1258, 2000)
S Andreadis et al.
JOURNAL OF VIROLOGY (2000)
Share Paper
